We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4,690.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
01/5/2018 11:26 | Fangorn2, that guide is years out of date. For example, it states that aim shares cannot be held in an isa unless they are dual listed. | biggest bill | |
01/5/2018 11:24 | Most brokers don’t really advertise this useful rule and some don’t permit foreign shares to be held in these accounts – especially with ISAs. To check whether your broker does or find one who will, see the UK stock broker comparison table. hxxps://bit.ly/2I3OB But that’s their decision, not the tax authorities. The UK regulations are clear. To qualify for an ISA, a stock must simply be listed on a recognised stock exchange. A list of recognised exchanges can be found on the HMRC website here. With SIPPs, almost any investments are permitted, including shares anywhere in the world. Some providers apply the same recognised stock exchange restriction for foreign shares, but others allow you to hold almost all overseas stocks and funds. | scothernman | |
01/5/2018 11:14 | "Guys if taken over can you have shares in Takeda in a ISA replacing Shire shares ?" Surprised Monty doesn't know this.... Most brokers don’t really advertise this useful rule and some don’t permit foreign shares to be held in these accounts – especially with ISAs. To check whether your broker does or find one who will, see the UK stock broker comparison table. Easy oversight to make though. | fangorn2 | |
01/5/2018 10:38 | Guys if taken over can you have shares in Takeda in a ISA replacing Shire shares ? | montyhedge | |
01/5/2018 10:20 | Thanks Philanderer for your regular updates over the last 6 months. Every board has an informer and analyser for the good of those long. Saw similarly another one on paysafe board where I made good money and that got taken over. Looks like this take over will happen by 8th may either way. Sold at 4090p and back in at 3850p. Great stock SHP to trade also without stamp duty with daily fluctuations with guaranteed drop on US open most days after any initial rise there. | scothernman | |
01/5/2018 10:05 | I think that as possibly sealed the deal. | montyhedge | |
01/5/2018 09:53 | Japanese takeover bid is at fair price, says Shire founder The founder of Shire has come out in support of a proposed takeover by a Japanese rival. Harry Stratford, 70, who launched the pharmaceuticals company from an office above a village off-licence near Basingstoke in the mid-1980s, said that a £46 billion proposal from Takeda represented a “fair price”. Many investors remain sceptical about the cash-and-shares offer because the Osaka-based company is smaller than Shire. The fall in Takeda’s shares in Tokyo has diluted the value of the proposal to below £46 billion. | philanderer | |
01/5/2018 08:15 | That would be acceptable for me otherwise could be back to 3400p if deal off. | montyhedge | |
01/5/2018 08:12 | Offer is currently worth 4768p being cash of 2206p and Takeda shares of 2562p | redtom1 | |
01/5/2018 07:13 | https://www.bloomber | steeplejack | |
01/5/2018 06:53 | Will probably know Tuesday 1am as well given takeda will likely release something or it will get leaked out to the press over the weekend. | nigelpm | |
01/5/2018 06:50 | Market closed on Monday, Bank holiday. So Tuesday we will know. Arbitrators will come if proposal turns into a bid. I would imagine all the advisors will be working bank holiday weekend. Fingers crossed fireworks next week, let's hope blue touch paper as been lite, lol | montyhedge | |
01/5/2018 00:43 | There was that ft speculation about Pfizer possibly maybe waiting in the wings. Not sure if there's any further extension likely beyond the 8th. We'll find out very soon. Could be an interesting few days ahead. | ruethewhirl | |
01/5/2018 00:25 | Because Takeda is Japanese this will happen from their side. My concern is shareholders and board in UK/Ireland/US. That's where the potential "no" is and that's what's in the price. | podgyted | |
30/4/2018 21:00 | Unchanged stateside from London close. Takeda in Japan trading from 1am | philanderer | |
30/4/2018 19:21 | mildly irritating for sure - but won't change the overall points I made. | nigelpm | |
30/4/2018 18:42 | PhilGood find that's why the fall then, wondered why. | montyhedge | |
30/4/2018 18:05 | May have started the slide today... 'Shire Sued For Breach Of Contract & Fraud In Patent Dispute' ...The complaint states that “the valuable patent rights LCS lost as a result of the wrongful conduct of Shire and its involved executives and counsel …. have a value into the billons,” notably as the patent’s term would not have expired until 2030 and Shire expects, in the meantime, to earn billions from the BED indication. | philanderer | |
30/4/2018 17:04 | From FT: Takeda’s $65bn takeover offer for Shire, say M&A bankers and lawyers, marks a pivotal moment for Japan. Corporate bosses, facing the realities of a rapidly ageing population, must formally acknowledge that long-term growth can only be found outside their shrinking nation. That growth, chief executives are deciding, must be bought in. Firestone, explains one banker, was a “nice to have” overseas purchase. “Everything Japan does from now on is a ‘must have’,” he adds. Whether or not it succeeds, Takeda’s offer for Shire represents the culmination of pressures now being felt across Japanese boardrooms as the Abenomics era of cheap financing and governance reform enters its sixth year. There is a compelling case for making overseas acquisitions: a government that, since 2013, has been explicit in its support for outbound deals; corporate governance-driven pressure to produce better returns on equity; and a banking sector that sees acquisition financing as an oasis of growth in a domestic market starved of loan demand. | nigelpm | |
30/4/2018 16:59 | phil Nice article, where did you find that, lol. | montyhedge | |
30/4/2018 16:55 | monty , I think it was Credit Suisse who said a 60% chance of going through and I agree with those odds. "Shire expects FDA approval in 2018" | philanderer | |
30/4/2018 16:50 | I actually feel I should be backing up the truck here. Why? --BID FAILS-- Given recent good results one would think it would settle back around the £32/£33 mark - perhaps higher - it might well immediately fall below £30 but that's fine as there might be an opportunity to buy more at that level. So downside is probably around 15% on balance. And that is in the short term. Another bidder might be waiting in the wings or Takeda could come back again. -- BID SUCCEEDS-- Minimum upside 20% - 25% as it stands but potential for more in medium term from a combined entity. Maybe I just like these situations too much but it is a classic odds in buyer's favour IMHO. | nigelpm | |
30/4/2018 16:43 | Bill I like that. | montyhedge | |
30/4/2018 16:30 | This is a hedge fund's view of the bid: In the article, the hedge fund manager makes the point that Japanese shareholders have never voted down a merger which has been proposed by the board of a company. | biggest bill |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions